Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
This study has been completed.
Study NCT00480883   Information provided by Combined Military Hospital, Pakistan

First Received on May 29, 2007.   Last Updated on June 1, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leishmaniasis, Cutaneous
Additional conditions recognized in this trial
Leishmaniasis
More general conditions related to this trial
Euglenozoa Infections
Parasitic Diseases
Protozoan Infections
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Parasitic
Interventions listed in this trial
meglumine antimoniate, allopurinol
meglumine antimoniate
Additional drug interventions recognized in this trial
Allopurinol
More general drug interventions related to this trial
Anti-Infective Agents
Antimetabolites
Antioxidants
Antiparasitic Agents
Antiprotozoal Agents
Antirheumatic Agents
Enzyme Inhibitors
Free Radical Scavengers
Gout Suppressants
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Combined Military Hospital, Pakistan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services